Page 109 - MI-2-3
P. 109

Microbes & Immunity                                                SARS-CoV-2 complementary classification



               doi: 10.1056/NEJMe2407575                          the SARS-CoV-2 sarbecovirus lineage responsible for the
                                                                  COVID-19 pandemic. Nat Microbiol. 2020;5(11):1408-1417.
            5.   He F, Deng Y, Li W. Coronavirus disease 2019: What we
               know? J Med Virol. 2020;92(7):719-725.             doi: 10.1038/s41564-020-0771-4
               doi: 10.1002/jmv.25766                          17.  Pereson MJ, Mojsiejczuk L, Martínez AP, Flichman  DM,
            6.   Joseph S, Kutty Narayanan A. Covid 19-the 21   century   Garcia GH, Di Lello FA. Phylogenetic analysis of
                                                   st
               pandemic: The novel coronavirus outbreak and the   SARS-CoV-2 in the first few months since its emergence.
               treatment strategies. Adv Pharm Bull. 2022;12(1):34-44.  J Med Virol. 2021;93(3):1722-1731.
               doi: 10.34172/apb.2022.005                         doi: 10.1002/jmv.26545
            7.   Sah P, Fitzpatrick MC, Zimmer CF,  et al. Asymptomatic   18.  Canuti M, Bianchi S, Kolbl O, et al. Waiting for the truth: is
               SARS-CoV-2 infection: A  systematic  review and meta-  reluctance in accepting an early origin hypothesis for SARS-
               analysis. Proc Natl Acad Sci U S A. 2021;118(34):e2109229118.  CoV-2 delaying our understanding of viral emergence? BMJ
                                                                  Glob Health. 2022;7(3):e008386.
               doi: 10.1073/pnas.2109229118
                                                                  doi: 10.1136/bmjgh-2021-008386
            8.   Gandhi RT, Lynch JB, Del Rio C. Mild or moderate Covid-19.
               N Engl J Med. 2020;383(18):1757-1766.           19.  Pekar JE, Magee A, Parker E,  et al. The molecular
                                                                  epidemiology of multiple zoonotic origins of SARS-CoV-2.
               doi: 10.1056/NEJMcp2009249                         Science. 2022;377(6609):960-966.
            9.   Çelik I, Öztürk R. From asymptomatic to critical illness:      doi: 10.1126/science.abp8337
               Decoding various clinical stages of COVID-19. Turk J Med
               Sci. 2021;51(Si-1):3284-3300.                   20.  Bukin YS, Bondaryuk AN, Kulakova NV, Balakhonov SV,
                                                                  Dzhioev YP, Zlobin VI. Phylogenetic reconstruction of the
               doi: 10.3906/sag-2107-137                          initial stages of the spread of the SARS-CoV-2 virus in the
            10.  Nikolich-Zugich J, Knox KS, Rios CT, Natt B, Bhattacharya D,   Eurasian and American continents by analyzing genomic
               Fain MJ. SARS-CoV-2 and COVID-19 in older adults: What   data. Virus Res. 2021;305:198551.
               we may expect regarding pathogenesis, immune responses,      doi: 10.1016/j.virusres.2021.198551
               and outcomes. GeroScience. 2020;42(2):505-514.
                                                               21.  Domingo JL. What we know and what we need to know about
               doi: 10.1007/s11357-020-00186-0                    the origin of SARS-CoV-2. Environ Res. 2021;200:111785.
            11.  Boyton RJ, Altmann DM. The immunology of asymptomatic      doi: 10.1016/j.envres.2021.111785
               SARS-CoV-2 infection: What are the key questions? Nat Rev
               Immunol. 2021;21(12):762-768.                   22.  Latinne A, Hu B, Olival KJ, et al. Origin and cross-species
                                                                  transmission of bat coronaviruses in China. Nat Commun.
               doi: 10.1038/s41577-021-00631-x                    2024;15(1):10705.
            12.  Naqvi AAT, Fatima K, Mohammad T,  et al. Insights into      doi: 10.1038/s41467-024-55384-7
               SARS-CoV-2 genome, structure, evolution, pathogenesis
               and therapies: Structural genomics approach.  Biochim   23.  Voskarides K. SARS-CoV-2: Tracing the origin, tracking the
               Biophys Acta Mol Basis Dis. 2020;1866(10):165878.  evolution. BMC Med Genomics. 2022;15(1):62.
               doi: 10.1016/j.bbadis.2020.165878                  doi: 10.1186/s12920-022-01208-w
            13.  Rahimi A, Mirzazadeh A, Tavakolpour S. Genetics and   24.  Lopes LR, de Mattos Cardillo G, Paiva PB. Molecular
               genomics of SARS-CoV-2: A review of the literature with   evolution and phylogenetic analysis of SARS-CoV-2
               the special focus on genetic diversity and SARS-CoV-2   and  hosts  ACE2  protein  suggest  Malayan  pangolin  as
               genome detection. Genomics. 2021;113(1 Pt 2):1221-1232.  intermediary host. Braz J Microbiol. 2020;51(4):1593-1599.
               doi: 10.1016/j.ygeno.2020.09.059                   doi: 10.1007/s42770-020-00321-1
            14.  Alwine JC, Casadevall A, Enquist LW, Goodrum  FD,   25.  Samson S, Lord É, Makarenkov V. Assessing the emergence
               Imperiale  MJ. A  critical analysis of the evidence for the   time of SARS-CoV-2 zoonotic spillover.  PLoS One.
               SARS-CoV-2 origin hypotheses. mSphere. 2023;8(2):e0011923.  2024;19(4):e0301195.
               doi: 10.1128/msphere.00119-23                      doi: 10.1371/journal.pone.0301195
            15.  Hao YJ, Wang YL, Wang MY, et al. The origins of COVID-19   26.  Ruiz-Aravena M, McKee C, Gamble A,  et  al. Ecology,
               pandemic:  A  brief  overview.  Transbound Emerg Dis.   evolution and spillover of coronaviruses from bats. Nat Rev
               2022;69(6):3181-3197.                              Microbiol. 2022;20(5):299-314.
               doi: 10.1111/tbed.14732                            doi: 10.1038/s41579-021-00652-2
            16.  Boni MF, Lemey P, Jiang X, et al. Evolutionary origins of   27.  Holmes EC, Goldstein SA, Rasmussen AL, et al. The origins of


            Volume 2 Issue 3 (2025)                        101                           doi: 10.36922/MI025190042
   104   105   106   107   108   109   110   111   112   113   114